What is CVE-2018-14787?

CVE-2018-14787 is a high-severity vulnerability in Philips Intellispace Cardiovascular, classified under Improper Privilege Management. CVSS score: 7.8/10. Published 2018-08-22.

How severe is CVE-2018-14787?

High severity. CVSS v3 base score is 7.8 out of 10.

Privilege escalation in Philips Intellispace Cardiovascular

CVE-2018-14787

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Vulnerability class: Privilege Escalation

Published 2018-08-22 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.004 (30.6th percentile), scored 2026-09-29.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 31st percentile — 30.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000

Affected products

Philips Intellispace Cardiovascular
Philips Intellispace Cardiovascular (Iscv) Products — versions IntelliSpace Cardiovascular, Version 3.1 or prior, Xcelera Version 4.1 or prior
Philips Xcelera

Weakness classification (CWE)

CWE-269 — Improper Privilege Management

References

www.usa.philips.com/healthcare/about/customer-support/product-security (Vendor Advisory)
ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 (US Government Resource, Third Party Advisory)

Frequently asked questions

What is CVE-2018-14787?: CVE-2018-14787 is a high-severity vulnerability in Philips Intellispace Cardiovascular, classified under Improper Privilege Management. CVSS score: 7.8/10. Published 2018-08-22.
How severe is CVE-2018-14787?: High severity. CVSS v3 base score is 7.8 out of 10.